Research with older people in a world with COVID-19: identification of current and future priorities, challenges and opportunities

SJ Richardson, CB Carroll, J Close, AL Gordon… - Age and …, 2020 - academic.oup.com
Older people are disproportionately affected by the COVID-19 pandemic, which has had a
profound impact on research as well as clinical service delivery. This commentary identifies …

[HTML][HTML] Stem cells: a comprehensive review of origins and emerging clinical roles in medical practice

…, L Ganti, AD Kaye, LI Mosel, CB Carroll… - Orthopedic …, 2022 - ncbi.nlm.nih.gov
Stem cells are types of cells that have unique ability to self-renew and to differentiate into
more than one cell lineage. They are considered building blocks of tissues and organs. Over …

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

CB Carroll, PG Bain, L Teare, X Liu, C Joint, C Wroath… - Neurology, 2004 - AAN Enterprises
Background: The long-term treatment of Parkinson disease (PD) may be complicated by the
development of levodopa-induced dyskinesia. Clinical and animal model data support the …

[HTML][HTML] Simvastatin as a potential disease-modifying therapy for patients with Parkinson's disease: rationale for clinical trial, and current progress

CB Carroll, RKH Wyse - Journal of Parkinson's disease, 2017 - content.iospress.com
Many now believe the holy grail for the next stage of therapeutic advance surrounds the
development of disease-modifying approaches aimed at intercepting the year-on-year …

Δ9‐tetrahydrocannabinol (Δ9‐THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease

CB Carroll, ML Zeissler, CO Hanemann… - Neuropathology and …, 2012 - Wiley Online Library
… Parkinson's disease - Carroll - 2012 - Neuropathology and Applied Neurobiology - Wiley
Online Library … Dr Carroll was an MRC post-doctoral fellow at the time of undertaking this work. …

Quantifying drug-induced dyskinesias in the arms using digitised spiral-drawing tasks

X Liu, CB Carroll, SY Wang, J Zajicek… - Journal of neuroscience …, 2005 - Elsevier
In this study, we quantify the severity of drug-induced dyskinesias in the arms of Parkinson's
disease (PD) patients using digitised spiral-drawing tasks. Two spiral drawings, namely a …

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel …

…, H Morris, P Limousin, D Athauda, CB Carroll… - BMJ open, 2021 - bmjopen.bmj.com
Introduction Parkinson’s disease (PD) is a common neurodegenerative disorder with substantial
morbidity. No disease-modifying treatments currently exist. The glucagon like peptide-1 …

Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS

EF Goodall, MJ Greenway, I Van Marion, CB Carroll… - Neurology, 2005 - AAN Enterprises
Iron misregulation promotes oxidative stress and abnormally high iron levels have been
found in the spinal cords of patients with ALS. The authors investigated whether HFE gene …

Digital health technology for non-motor symptoms in people with Parkinson's disease: Futile or future?

…, J Sringean, D Trivedi, CB Carroll… - Parkinsonism & related …, 2021 - Elsevier
Introduction There is an ongoing digital revolution in the field of Parkinson's disease (PD)
for the objective measurement of motor aspects, to be used in clinical trials and possibly …

Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project

MD Witham, E Anderson, CB Carroll, PM Dark… - BMJ open, 2020 - bmjopen.bmj.com
Objective To provide guidance to researchers, funders, regulators and study delivery teams
to ensure that research on COVID-19 is inclusive, particularly of groups disproportionately …